RodrÃguez Prieto MA et al. |
Treatment of lentigo maligna with azelaic acid. |
1993 |
Int. J. Dermatol. |
pmid:8505164
|
Banerjee S et al. |
2'-(3 alpha-Benzyloxy-24-norcholan-23-yl)-2',4',4'-trimethyl-4',5'- dihydrooxazoline-N-oxyl as a potential spin probe for model membranes. |
1994 |
Steroids |
pmid:7940616
|
Pattarino F et al. |
Topical delivery systems for azelaic acid: effect of the suspended drug in microemulsion. |
1994 |
Pharmazie |
pmid:8140138
|
Ferioli V et al. |
Determination of azelaic acid in pharmaceuticals and cosmetics by RP-HPLC after pre-column derivatization. |
1994 |
Farmaco |
pmid:8074784
|
Bojar RA et al. |
Disruption of the transmembrane pH gradient--a possible mechanism for the antibacterial action of azelaic acid in Propionibacterium acnes and Staphylococcus epidermidis. |
1994 |
J. Antimicrob. Chemother. |
pmid:7829407
|
Nguyen QH and Bui TP |
Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. |
1995 |
Int. J. Dermatol. |
pmid:7737781
|
U-Taniguchi Y et al. |
Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors. |
1995 |
Oncol. Res. |
pmid:8555652
|
Grimes PE |
Melasma. Etiologic and therapeutic considerations. |
1995 |
Arch Dermatol |
pmid:7492140
|
Lemic-Stojcevic L et al. |
Effect of azelaic acid on melanoma cells in culture. |
1995 |
Exp. Dermatol. |
pmid:7640879
|
Gatti R et al. |
Analysis of aliphatic dicarboxylic acids in pharmaceuticals and cosmetics by liquid chromatography (HPLC) with fluorescence detection. |
1995 |
J Pharm Biomed Anal |
pmid:9696574
|